VistaGen Therapeutics Inc. (VTGN)
Vistagen to Participate in Stifel Healthcare Conference 2025
Henry Schein Inc (HSIC)
VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend
MaxCyte Inc (MXCT)
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
STRATA Skin Sciences Inc (SSKN)
STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
NuCana plc (NCNA)
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
bioAffinity Technologies Inc. (BIAFW)
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
Xtant Medical Holdings Inc. (XTNT)
Xtant Medical Announces Commercial Launch of CollagenX™
NewAmsterdam Pharma (NAMS)
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Lexeo Therapeutics Inc. (LXEO)
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Marker Therapeutics Inc. (MRKR)
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors